Eli Lilly stops drug study; Twitter layoff reports; Barron's expects Mattel to rise 35%
Time for your daily dose of trending tickers, the stocks you're following based on your Yahoo Finance ticker searches.
Twitter (TWTR) got slammed as Jack Dorsey officially takes charge. Investors and employees are on edge after reports Twitter plans to announce layoffs this week. The social media company is struggling to stay relevant. Re/Code, who broke the news, said it is not clear how many of Twitter's 4,200 workers will be let go.
Eli Lilly
Eli Lilly (LLY) tanked for stopping studies for its heart-disease drug, Evacetrapib. The pharmaceutical giant is ending development of the treatment because it was found to be not effective enough. But shares of Esperion Therapeutics (ESPR), which makes a similar drug rose on the news. Eli Lilly will take a fourth quarter charge of as much as $90 million for costs related to the drug.
Get the Latest Market Data and News with the Yahoo Finance App
Mattel
Mattel (MAT) is finally looking up after years of declines. The world's largest toymarker got a positive report from Barron's saying it could stage a comeback and rise 35% in a year. The financial newspaper said the new interactive 'Hello Barbie' - which uses voice recognition and Wi-Fi along with its 7% dividend yield are game changers for the stock.